NCT00035763

Brief Summary

To measure the variability in pain and response to pain in sickle cell disease, and to build multivariate models to explain both patients' pain and their response to pain, especially, utilization of health care.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Oct 2001

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2001

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 4, 2002

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 6, 2002

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2006

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2006

Completed
Last Updated

March 24, 2016

Status Verified

January 1, 2008

Enrollment Period

4.8 years

First QC Date

May 4, 2002

Last Update Submit

March 23, 2016

Conditions

Eligibility Criteria

Age16 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
No eligibility criteria

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Related Publications (1)

  • Smith WR, Bovbjerg VE, Penberthy LT, McClish DK, Levenson JL, Roberts JD, Gil K, Roseff SD, Aisiku IP. Understanding pain and improving management of sickle cell disease: the PiSCES study. J Natl Med Assoc. 2005 Feb;97(2):183-93.

    PMID: 15712781BACKGROUND

MeSH Terms

Conditions

Hematologic DiseasesAnemia, Sickle Cell

Condition Hierarchy (Ancestors)

Hemic and Lymphatic DiseasesAnemia, Hemolytic, CongenitalAnemia, HemolyticAnemiaHemoglobinopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Wally Smith

    Virginia Commonwealth University

Study Design

Study Type
observational
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 4, 2002

First Posted

May 6, 2002

Study Start

October 1, 2001

Primary Completion

August 1, 2006

Study Completion

August 1, 2006

Last Updated

March 24, 2016

Record last verified: 2008-01